Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to see how cancer treatment affects sexual and reproductive function. The patient will also be asked to participate in blood draws to see if and how cancer treatment affects the ovaries and the ability to have children (fertility). These blood draws are optional and the patient can still participate in the questionnaire portion of the study even if they choose not to have their blood drawn.
Eligibility criteria
Qualifiers
Women, 18 years of age and older
Premenopausal women at time of diagnosis who have either been pregnant or had at least one menstrual period in the last 12 months
Note: premenopausal women at time of diagnosis who have not been pregnant or have not had at least one menstrual period in the last 12 months are able to participate only if they have had an intrauterine device (IUD) in place within the last 12 months.
Women with newly diagnosed breast cancer (stage 0-III) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
Disqualifiers
Active secondary cancer requiring cytotoxic chemotherapy
Prior systemic treatment for a malignancy
Trial design
Treatments tested in this trial
- surveys
- Blood draw
- Transvaginal ultrasounds
Treatment groups
475 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov